| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/23/2001 | WO2001060325A1 Pharmaceutical composition |
| 08/23/2001 | WO2001060324A1 Skin preparations for external use |
| 08/23/2001 | WO2001060319A2 Polyhydroxylated benzene-containing compounds |
| 08/23/2001 | WO2001060318A2 Protection of the female reproductive system from natural and artificial insults |
| 08/23/2001 | WO2001060315A2 Method for the treatment or prevention of flavivirus infections using nucleoside analogues |
| 08/23/2001 | WO2001060312A1 Device for calculating elixir doses appropriate for a patient's weight |
| 08/23/2001 | WO2001060179A1 Improvements in or relating to solubilisation of flavonols |
| 08/23/2001 | WO2001060176A1 Inulin products with improved nutritional properties |
| 08/23/2001 | WO2001060174A2 Weight loss induced by reduction in neuropeptide y level |
| 08/23/2001 | WO2001025422A3 Antisense compositions and cancer-treatment methods |
| 08/23/2001 | WO2001024803A3 Pharmaceutical compositions containing copper, salicylic acid and vitamines c |
| 08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
| 08/23/2001 | WO2001013903A3 Treatment of restless leg syndrome with a combination of clonidine and opioid |
| 08/23/2001 | WO2001013902A3 Combination of active agents, said combination containing clonidine and pramipexol |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001012159A3 Artificial tear replacement solution |
| 08/23/2001 | WO2001010816A3 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 08/23/2001 | WO2001010422A3 Use of hepoxilins or hepoxilin analogs as antidiabetics, antiinframmatory agents |
| 08/23/2001 | WO2001010387A3 Antiviral therapy use of P-glycoprotein modulators |
| 08/23/2001 | WO2001009298A3 Strategy for carbohydrate-based cancer vaccines |
| 08/23/2001 | WO2001008704A3 Dendrimer-photosensitizer complexes for medical applications |
| 08/23/2001 | WO2001008668A3 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders |
| 08/23/2001 | WO2001008633A3 An improved form of form I celiprolol hydrochloride |
| 08/23/2001 | WO2001007637A3 Conditionally controlled, attenuated HIV vaccine |
| 08/23/2001 | WO2001007611A3 Novel polynucleotides and method for the use thereof |
| 08/23/2001 | WO2001007436A3 Substituted oxoazaheterocyclyl compounds |
| 08/23/2001 | WO2001007029A3 Substituted guanidines and the use thereof |
| 08/23/2001 | WO2001005356A3 Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant |
| 08/23/2001 | WO2001004116A3 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
| 08/23/2001 | WO2000074634A3 Methods and compositions for modulating cell proliferation and cell death |
| 08/23/2001 | WO2000071520A3 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors |
| 08/23/2001 | WO2000071508A3 Inhibitors of factor Xa |
| 08/23/2001 | WO2000067738A3 The use of a protein tyrosine kinase pathway inhibitor in the treatment of ocular disorders |
| 08/23/2001 | WO2000061126A3 Method of treating neurological disorders with combinations of nitric oxide synthase inhibitors and excitatory amino acid receptor modulators |
| 08/23/2001 | WO2000059484A3 Use of arylalkanoylpyridazines |
| 08/23/2001 | WO2000056294A3 Carnitine supplemented diet to prevent sudden death syndrome in broiler breeder type poultry |
| 08/23/2001 | WO2000050023A3 Use of tamoxifen and related compounds as CLC3 blockers in the treatment of vascular diseases |
| 08/23/2001 | WO2000044364A3 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant |
| 08/23/2001 | WO2000044363A3 Desmethylsildenafil compositions and uses for treating angina and erectile dysfunctions |
| 08/23/2001 | WO2000038662A3 The manipulation of the activity of a nitric oxide radical production pathway for the treatment of diseases associated with the presence of oxygen free radicals |
| 08/23/2001 | WO2000027379A3 Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives |
| 08/23/2001 | WO2000023066A3 Irrigation solution and method for inhibition of pain and inflammation |
| 08/23/2001 | WO2000021514A3 Method and composition for treating and preventing tuberculosis |
| 08/23/2001 | WO2000006738A3 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 08/23/2001 | US20010016776 Spine distraction implant and method |
| 08/23/2001 | US20010016731 Methods and apparatus for accelerated orthokeratology |
| 08/23/2001 | US20010016661 Indolealkanoic acid derivatives inhibits aldose reductase and useful for treating chronic complication associated with diabetes mellitus including diabetic cataracts, retinopathy, nephropathy and neuropathy |
| 08/23/2001 | US20010016660 Reacting difunctional alkanes containing halogen or aliphatic or aromataic sulfonyloxide reactive functional groups with 4-aminopyrimidine derivative in presence of water and organic solvent (alcohols, glycols, polyglycols, mono or diethers) |
| 08/23/2001 | US20010016659 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/23/2001 | US20010016606 A container with an opening that has a closure that can be released to dispense propanethial-s-oxide, which is held in an interior compartment in individual dosages of a strength to induce tearing in a mammalian eye |
| 08/23/2001 | US20010016604 Mixing a cosmetic or pharmaceutical agent in a vehicle for topical administration to the skin of humans or animals with hydroxycarboxylic acid and related ketocarboxylic acid and ester, lactone or salt forms |
| 08/23/2001 | US20010016603 Calcium formate for use as a dietary supplement |
| 08/23/2001 | US20010016601 Use of triaqua-u3-oxohexakis-u-propionatotrichromium(1+), [Cr3O(O2CCH2CH3)6(H2O)3]+, as a nutritional supplement or in treatment of medical conditions |
| 08/23/2001 | US20010016600 Method of treating cancer using dithiocarbamate derivatives |
| 08/23/2001 | US20010016597 Hypotensive agents; vision defects |
| 08/23/2001 | US20010016596 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/23/2001 | US20010016595 Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
| 08/23/2001 | US20010016594 Medicament |
| 08/23/2001 | US20010016593 Multilayer |
| 08/23/2001 | US20010016592 Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them |
| 08/23/2001 | US20010016591 Fungicidal active compound combinations |
| 08/23/2001 | US20010016590 Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
| 08/23/2001 | US20010016588 Antiallergens; antitumor agents; anticancer agents |
| 08/23/2001 | US20010016586 Use of organic compounds |
| 08/23/2001 | US20010016584 Synergistic mixture of acetaminophen and buspirone |
| 08/23/2001 | US20010016583 Therapeutic application of pro-apoptotic benzodiazepines |
| 08/23/2001 | US20010016582 Synergystic administration of D1 and D2 dopamine agonists to reduce body weight, body fat; blood insulin, glucose, lipid, and lipidprotein |
| 08/23/2001 | US20010016581 Separation of cephalosporin isomers |
| 08/23/2001 | US20010016580 In combination with nicotinic acid, picolinic acid or both useful for dietary supplementation, lowering blood glucose or serum lipid levels and increasing body mass; enteric-coated tablets, capsules or microbeads |
| 08/23/2001 | US20010016579 Serotonin 5-HT, receptor partial activator |
| 08/23/2001 | US20010016578 Eliminates problems associated with prolonged therapy associated with estrogenic steroids, progesterone synthesis inhibitor; counteract endometrial hyperstimulation, hyperplasia or carcinoma |
| 08/23/2001 | US20010016577 Aqueous liquid containing active ingredient, clay, and a gum; protective coatings; retention; nausea, heartburn, diarrhea; side effect reduction |
| 08/23/2001 | US20010016576 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 08/23/2001 | US20010016574 9a,11b-dehydro derivatives of 9-oxime-3-keto-6-O- methylerythromycin |
| 08/23/2001 | US20010016573 Administering an anthocyanin or cyanidin from cherries; intestinal adenomas; antitumor and carcinogenic agents |
| 08/23/2001 | US20010016572 Fructan-containing material subjected to partial hydrolysis low in glucose, fructose, and saccharose one-step ensymatic treatment; used in food, drugs, cosmetics |
| 08/23/2001 | US20010016570 Bone disorders |
| 08/23/2001 | US20010016569 Complexes |
| 08/23/2001 | US20010016568 Zinc chelate dimeric cell surface receptor antagonist |
| 08/23/2001 | US20010016346 Pedtidyl-prolyl cis-trans isomerase inhibitors and uses therefore |
| 08/23/2001 | US20010016343 Derivatized biotin compounds and methods |
| 08/23/2001 | US20010016339 Pancreatic polypeptide |
| 08/23/2001 | US20010016329 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 08/23/2001 | US20010016325 Activation of novel estrogen receptor supports and neuronal viability and function |
| 08/23/2001 | US20010016218 Method for production of arachidonic acid |
| 08/23/2001 | US20010016212 Topical mixture of organic chicken and hen herb, organic ruta herb, unsalted butter and pure beeswax; for various skin disorders such as eczema, dryness, itchiness |
| 08/23/2001 | US20010016209 Molecular dispersion composition with enhanced bioavailability |
| 08/23/2001 | US20010016207 Compounds such as N-(1-(cyanomethylcarbamoyl)cyclohexyl)-4-(piperazin-1-yl)-benzamide |
| 08/23/2001 | US20010016206 For delivery of water insoluble active retinoid agents comprising a vehicle for initially dissolving the active agent, emulsifier and capsule shell formulated to open in the gastrointestinal tract |
| 08/23/2001 | US20010016197 Cultivating a fungi of the basidiomycetes in a submerged culture on nutrient media, isolating the biomass of edible mushrooms from the culture broth, and drying at a range of 40-45 degrees celsius |
| 08/23/2001 | US20010016196 Immunoliposomes that optimize internalization into target cells |
| 08/23/2001 | US20010016194 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
| 08/23/2001 | US20010016189 Stable, aqueous cationic hydrogel |
| 08/23/2001 | EP1143945A3 Carnitine supplemented diet to prevent sudden death syndrome in broiler breeder type poultry |
| 08/23/2001 | EP1143944A3 Use of arylalkanoylpyridazines |
| 08/23/2001 | DE10038110A1 Pharmazeutische Zusammensetzungen Pharmaceutical compositions |
| 08/23/2001 | DE10032137A1 Verfahren zur Herstellung von Phenothiazin-Granulat mit verbesserten Eigenschaften Process for the preparation of phenothiazine granules having improved properties |
| 08/23/2001 | DE10008050A1 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure zur Behandlung von Infektionskrankheiten Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid for the treatment of infectious diseases |
| 08/23/2001 | DE10007203A1 Composition for treating allergic and/or vasomotor rhinitis or allergic conjunctivitis by topical or oral administration, contains synergistic combination of non-sedating antihistamine and leukotriene antagonist |
| 08/23/2001 | DE10006989A1 Pharmaceutical or dietetic preparation for preventing cellular adhesion of pathogens, e.g. in treatment of infections, comprising carbohydrate having double bond-containing terminal uronic acid unit |